[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100519091":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":12,"locations":17,"responsibleParty":34,"collaborators":7,"id":36,"slug":37,"hasResults":38,"nctId":39,"briefTitle":40,"officialTitle":41,"acronym":7,"eligibilityCriteria":42,"healthyVolunteers":38,"sex":43,"minAge":44,"maxAge":7,"enrollmentInfo":45,"targetDuration":7,"studyType":48,"phases":7,"briefSummary":49,"conditions":50,"keywords":52,"overallStatus":53,"whyStopped":7,"lastUpdateSubmitDate":54,"lastUpdatePostDateStruct":55,"startDateStruct":58,"completionDateStruct":60,"leadSponsor":62,"locationsCount":63},{"fullName":5,"class":6},"Power Life Sciences Inc.","INDUSTRY",null,[9],{"name":10,"affiliation":5,"role":11},"Michael B Gill","STUDY_DIRECTOR",[13],{"name":10,"role":14,"phone":15,"phoneExt":7,"email":16},"CONTACT","415-900-4227","bask@withpower.com",[18],{"facility":19,"status":7,"city":20,"state":21,"zip":22,"country":23,"countryCode":24,"cosmosGeoPoint":25,"geoPoint":30,"contacts":31},"Power Life Sciences","San Francisco","California","94107","United States","US",{"type":26,"coordinates":27},"Point",[28,29],-122.41942,37.77493,{"lat":29,"lon":28},[32],{"name":10,"role":14,"phone":15,"phoneExt":7,"email":33},"https:\u002F\u002Fwww.withpower.com\u002Fcontact-us@withpower.com",{"type":35,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100519091","exploring-merkel-cell-carcinoma-clinical-trial-engagement-patterns-100519091",false,"NCT06039033","Exploring Merkel Cell Carcinoma Clinical Trial Engagement Patterns","Merkel Cell Carcinoma Clinical Trials: What Are Prevailing Patient Experiences in Merkel Cell Carcinoma Studies","Inclusion Criteria:\n\n* Aged ≥ 18 years old\n* Able to comprehend the investigational nature of the protocol and provide informed consent\n* Diagnosis of Merkel cell carcinoma\n\nExclusion Criteria:\n\n* No diagnosis of Merkel cell carcinoma confirmed\n* Inability to perform regular electronic reporting\n* Patient does not understand, sign, and return consent form","ALL","18 Years",{"count":46,"type":47},500,"ESTIMATED","OBSERVATIONAL","Taking part in medical research usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups.\n\nThis study will admit a wide range of data on the clinical trial experience of Merkel cell carcinoma patients to determine which factors prevail in limiting a patient's ability to join or finish a trial.\n\nIt will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future Merkel cell carcinoma patients.",[51],"Merkel Cell Carcinoma",[51],"NOT_YET_RECRUITING","2023-09-08",{"date":56,"type":57},"2023-09-15","ACTUAL",{"date":59,"type":47},"2024-10",{"date":61,"type":47},"2026-10",{"name":5,"class":6},1]